ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

计划入组 6 人 · 首次发布于 2025 年 10 月 20 日

A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease) (BAG3 DCM)

计划入组 35 人 · 首次发布于 2023 年 8 月 8 日

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

计划入组 8 人 · 首次发布于 2025 年 8 月 22 日

Dilated cardiomyopathy therapy (Maze Therapeutics)

LMNA gene therapy (LMNA-related dilated cardiomyopathy)

AAV-BAG3

Lexeo Therapeutics

United States

LABORATORIOS BAGO S.A.

Argentina

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Affinia Therapeutics Partners with DCM Foundation to Advance BAG3 Dilated Cardiomyopathy Awareness and Genetic Testing

Affinia Therapeutics Raises $40M Series C to Advance First-in-Class Gene Therapy for BAG3 Dilated Cardiomyopathy

Affinia Therapeutics Advances AFTX-201 for BAG3 Dilated Cardiomyopathy